The Chinese screening model for asthma-chronic obstructive pulmonary disease overlap (ACO) appears to be feasible, potentially offering a simple tool for clinicians to efficiently diagnose ACO, according to a recent study.
Patients with chronic obstructive pulmonary disease (COPD) are at significantly increased risk for all-cause mortality compared to those without COPD, with lung cancer and chronic lower airway disease being the leading causes of death in at-risk patients, particularly those aged <60 years, reveals a study.
Serum levels of S100 calcium‐binding protein A4 (S100A4) appear to be a helpful biomarker in predicting disease progression or mortality in patients with idiopathic pulmonary fibrosis (IPF), suggests a recent study.
There appears to be a low overall incidence of respiratory adverse events during intramuscular (IM) ketamine sedation in paediatric patients in an emergency department (ED) in Singapore, reports a study. Increased incidence is significantly predicted by age <3 years and a higher initial dose of IM ketamine (4 mg/kg), while a lower risk is associated with manipulation and reduction procedures.
Type 2 diabetes mellitus (T2DM) patients with HbA1c levels of 7–9 percent are at slightly higher risk of chronic obstructive pulmonary disorder (COPD) compared with their peers who have good glycaemic control, a study has found.
Having migraine during midlife appears to be associated with a higher risk of developing dementia in later life, according to a large population-based longitudinal Danish study presented at the AHS* 2020 Virtual Meeting, indicating that migraine may be a risk factor for dementia.
Patients with psoriatic arthritis (PsA) often suffer from liver abnormalities, which are associated with higher body mass index (BMI), daily consumption of alcohol, more severe disease, and some therapies, according to a recent study.
Pembrolizumab in combination with chemotherapy significantly improves progression-free survival (PFS) vs chemotherapy alone in patients with previously untreated, locally recurrent inoperable or metastatic triple-negative breast cancer (TNBC), results of the KEYNOTE-355 study have shown.